Ⅰ型膠原交聯(lián)氨基端肽(NTXI)檢測試劑盒(酶聯(lián)免疫吸附試驗法)
ELISA Kit for Cross Linked N-Telopeptide Of Type I Collagen (NTXI)
NTX-I; NTX1
- 編號CEA639Hu
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 實驗方法競爭抑制
- 反應時長2h
- 檢測范圍2.47-200ng/mL
- 靈敏度最小可檢測劑量小于等于0.92ng/mL.
- 樣本類型Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 下載 英文說明書 中文說明書
- 規(guī)格 48T96T 96T*5 96T*10 96T*100
- 價格 ¥ 2646 ¥ 3780 ¥ 17010 ¥ 32130 ¥ 264600
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
特異性
本試劑盒用于檢測Ⅰ型膠原交聯(lián)氨基端肽(NTXI),經(jīng)檢測與其它相似物質(zhì)無明顯交叉反應。
由于受到技術(shù)及樣本來源的限制,不可能完成對所有相關(guān)或相似物質(zhì)交叉反應檢測,因此本試劑盒有可能與未經(jīng)檢測的其它物質(zhì)有交叉反應。
回收率
分別于定值血清及血漿樣本中加入一定量的Ⅰ型膠原交聯(lián)氨基端肽(NTXI)(加標樣品),重復測定并計算其均值,回收率為測定值與理論值的比率。
樣本 | 回收率范圍(%) | 平均回收率(%) |
serum(n=5) | 84-101 | 89 |
EDTA plasma(n=5) | 99-105 | 102 |
heparin plasma(n=5) | 78-98 | 81 |
精密度
精密度用樣品測定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差:取同批次試劑盒對低、中、高值定值樣本進行定量檢測,每份樣本連續(xù)測定20 次,分別計算不同濃度樣本的平均值及SD值。
批間差:選取3個不同批次的試劑盒分別對低、中、高值定值樣本進行定量測定,每個樣本使用同一試劑盒重復測定8次,分別計算不同濃度樣本的平均值及SD值。
批內(nèi)差: CV<10%
批間差: CV<12%
線性
在定值血清及血漿樣本內(nèi)加入適量的Ⅰ型膠原交聯(lián)氨基端肽(NTXI),并倍比稀釋成1:2,1:4,1:8,1:16的待測樣本,線性范圍即為稀釋后樣本中Ⅰ型膠原交聯(lián)氨基端肽(NTXI)含量的測定值與理論值的比率。
樣本 | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 92-99% | 95-103% | 88-97% | 85-94% |
EDTA plasma(n=5) | 95-102% | 84-93% | 98-105% | 87-104% |
heparin plasma(n=5) | 88-99% | 90-98% | 98-105% | 95-102% |
穩(wěn)定性
經(jīng)測定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
為減小外部因素對試劑盒破壞前后檢測值的影響,實驗室的環(huán)境條件需盡量保持一致,尤其是實驗室內(nèi)溫度、濕度及溫育條件。其次由同一實驗員來進行操作可減少人為誤差。
實驗流程
1. 實驗前標準品、試劑及樣本的準備;
2. 加樣(標準品及樣本)50µL,
加入50µL檢測液A(臨用前配制);
37°C溫育1小時。
3. 洗板3次;
4. 加檢測溶液B100µL,37°C孵育30分鐘;
5. 洗板5次;
6. 加TMB底物90µL,37°C孵育10-20分鐘;
7. 加終止液50µL,立即450nm讀數(shù)。
實驗原理
本試劑盒應用競爭抑制酶聯(lián)免疫分析法測定標本中待測物質(zhì)水平。將Ⅰ型膠原交聯(lián)氨基端肽(NTXI)單克隆抗體包被微孔板,制成固相載體,往包被抗體的微孔中同時加入生物素標記的抗原和待測抗原(標準品或樣本),待測抗原與生物素標記抗原對特異性抗體進行競爭結(jié)合。溫育后經(jīng)洗滌去掉未結(jié)合物,然后加入HRP標記的親和素,經(jīng)過溫育和徹底洗滌后加入底物TMB顯色。TMB在過氧化物酶的催化下轉(zhuǎn)化成藍色,并在酸的作用下轉(zhuǎn)化成最終的黃色。待測標本濃度越高,標記抗原和抗體的結(jié)合就越受到抑制,顯色愈淺。顯色的深淺與酶量呈正相關(guān),而與樣品中待測物質(zhì)含量呈負相關(guān)。用酶標儀在450nm波長下測定吸光度(O.D.值),計算樣品濃度。
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) |
SPA639Hu01 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)合成多肽 | Immunogen; Blocking Peptide. |
CPA639Hu11 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)牛血清白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
CPA639Hu21 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
PAA639Hu01 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)多克隆抗體 | WB; IHC; ICC; IP. |
LAA639Hu61 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)多克隆抗體(吲哚菁綠標記) | IHC; ICC; IP. |
MAA639Hu21 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)單克隆抗體 | WB; IHC; ICC; IP. |
MAA639Hu22 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)單克隆抗體 | WB; IHC; ICC; IP. |
MAA639Hu23 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)單克隆抗體 | WB; IHC; ICC; IP. |
MAA639Hu24 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)單克隆抗體 | WB; IHC; ICC; IP. |
MAA639Hu25 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)單克隆抗體 | WB; IHC; ICC; IP. |
MAA639Hu28 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)單克隆抗體 | WB; IHC; ICC; IP. |
LAA639Hu84 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)單克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
CEA639Hu | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA639Hu | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSA639Hu11 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
雜志 | 參考文獻 |
Nutrition | Dyslipidemic high-fat diet affects adversely bone metabolism in mice associated with impaired antioxidant capacity [ScienceDirect: S0899900709004717] |
Bone | Differential mRNA expression profiles in proximal tibia of aged rats in response to ovariectomy and low-Ca diet [ScienceDirect: S875632820800776X] |
Journal of Orthopaedic Research | Promotion of bone formation by naringin in a titanium particle‐induced diabetic murine calvarial osteolysis model [Wiley: Source] |
The Journal of Clinical Endocrinology & Metabolism | A Mediterranean Diet Enriched with Olive Oil Is Associated with Higher Serum Total Osteocalcin Levels in Elderly Men at High Cardiovascular Risk [PubMed: PMC3462931] |
Acta Paediatr.? | Biochemical markers of bone resorption are present in human milk: implications for maternal and neonatal bone metabolism [Pubmed:25109232] |
PLoS One. | An NMR Metabolomic Study on the Effect of Alendronate in Ovariectomized Mice [Pubmed:25184758] |
J Bone Miner Res | Strontium Ranelate Reduces the Fracture Incidence in a Growing Mouse Model of Osteogenesis Imperfecta [PubMed: 26679066] |
Journal of Functional Foods | Comparative effects of brown and golden flaxseeds on body composition, inflammation and bone remodelling biomarkers in perimenopausal overweight women [S1756464617301561] |
Archives?of?Oral?Biology | Impact?of a?chronic?smoking?habit?on the?osteo-immunoinflammatory?mediators?in the?peri-implant?fluid?of?clinically?healthy?dental?implants. [pubmed:27328151] |
Journal of Periodontology | Impact of a triclosan‐containing toothpaste during the progression of experimental peri‐implant mucositis: Clinical parameters and local pattern of osteo?… [Pubmed:29520826] |
Clinical?oral?implants?research | Triclosan‐containing fluoride toothpaste on clinical parameters and osteo‐inflammatory mediators when applied in a stent during experimental peri‐implant mucositis?… [Pubmed: 30659666] |
Molecular Therapy-Nucleic Acids | AAV-anti-miR-214 prevents collapse of the femoral head in osteonecrosis by regulating osteoblast and osteoclast activities [Pubmed: 31739209] |
Bioengineering (Basel) | Material-Dependent Formation and Degradation of Bone Matrix—Comparison of Two Cryogels [Pubmed: 32517006] |
BioMed Research International | Comparable Effects of Strontium Ranelate and Alendronate Treatment on Fracture Reduction in a Mouse Model of Osteogenesis Imperfecta [33506016] |
PHARMACEUTICAL BIOLOGY | Effects of icariin on the fracture healing in young and old rats and its mechanism [34511043] |
Evid Based Complement Alternat Med | Gujiansan Ameliorates Avascular Necrosis of the Femoral Head by Regulating Autophagy via the HIF-1α/BNIP3 Pathway [34512780] |